UCIBIO Researchers secure funding in FCT’s highly competitive RESTART Programme
Two UCIBIO researchers, Susana Pereira and Mariana Barbosa, have been awarded funding under the highly competitive RESTART Programme by the Fundação para a Ciência e a Tecnologia (FCT, I.P.).
UCIBIO Director Paula Videira finalist for the 2026 European Inventor Award
Paula Videira, Director of UCIBIO and leader of the Glycoimmunology Research Lab at UCIBIO-NOVA FCT, has been selected as a finalist for the prestigious 2026 European Inventor Award. The nomination recognizes the development of L2A5, a breakthrough antibody that identifies cancer-specific molecular signatures with unprecedented precision.
UCIBIO researchers uncover 12 years of genomic evolution in a high-priority hospital pathogen
A study led by the Bact_Drugs Lab at UCIBIO-Porto, published in Genome Medicine, reveals how Enterococcus faecium uses "linear plasmids" and antimicrobial peptides to outcompete rivals and evade infection control.
Pioneering Sustainable Health: UCIBIO partners in the new NOVA_i4SF Centre of Excellence
NOVA FCT has secured a remarkable achievement by winning the leadership of the NOVA Institute For A Sustainable Future (NOVA_i4SF). This project was selected under the highly competitive European Commission Teaming for Excellence program, emerging as one of only six Portuguese projects approved among a select group of 19 funded across Europe.